Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tiny Cup Improves Drug Delivery For Retinal Diseases
A new drug delivery system that uses a tiny silicone cup filled with any drug and sealed to the outer surface (episclera) of the eyeball may offer a
A new drug delivery system that uses a tiny silicone cup filled with any drug and sealed to the outer surface (episclera) of the eyeball may offer a
Labopharm’s revenue for the second quarter of fiscal 2009 increased to $6.3m from $4.9m in the second quarter of fiscal 2008. Revenue for the first half of fiscal
Watson has announced that one lot of 100mcg/hr Fentanyl Transdermal System patches sold in the US, is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are
Novavax has reported a net loss of $8.5m, or $0.10 per share, for the second quarter of 2009 compared to a net loss of $9.4m, or $0.15 per
Merck & Co.’s shareholders have approved the proposed merger with Schering-Plough. The preliminary tabulation indicates that more than 99% of the company’s outstanding shares voted in favor of
ALDA Pharmaceuticals (ALDA) has reported that in tests conducted at an independent laboratory in the US, T36 Antiseptic Hand Sanitizer has been shown to completely kill the new
Sanofi Pasteur has submitted to the FDA, a supplemental application for licensure of its influenza A(H1N1) 2009 monovalent vaccine. Responding to recent recommendations by the FDA, the company’s
GeoVax Labs, an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by HIV-1 and other infectious agents, has recorded a net loss of $1.34m for the three
Molecular Insight has initiated a pivotal phase 2 clinical trial of Azedra for the treatment of malignant pheochromocytoma, a type of neuroendocrine cancer. The single-arm trial will evaluate
FDA has approved Bayer HealthCare Pharmaceuticals’ 3000 IU vial size of Kogenate FS, antihemophilic factor (recombinant). The company said that the 3000 IU vial may eliminate the need